DOJ intervenes in whistleblower suit against Mallinckrodt

Pharmaceuticals

The Department of Justice has intervened in a whistleblower lawsuit against Mallinckrodt over allegations the drug maker knowingly underpaid Medicaid rebates it owed due to significant price increases to its drug Acthar.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.